Verition Fund Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,032
Closed -$464K 3592
2025
Q4
$464K Sell
11,032
-31,434
-74% -$1.27M ﹤0.01% 2717
2025
Q3
$1.46M Buy
+42,466
New +$1.22M 0.01% 2239
2025
Q2
Sell
-8,807
Closed -$261K 3883
2025
Q1
$261K Sell
8,807
-5,861
-40% -$223K ﹤0.01% 2927
2024
Q4
$581K Sell
14,668
-23,989
-62% -$908K ﹤0.01% 2388
2024
Q3
$1.32M Buy
+38,657
New +$1.09M 0.01% 1693
2023
Q3
Sell
-9,925
Closed -$253K 2699
2023
Q2
$253K Sell
9,925
-3,745
-27% -$90.8K ﹤0.01% 1688
2023
Q1
$305K Buy
+13,670
New +$330K ﹤0.01% 1514
2019
Q3
Sell
-8,679
Closed -$247K 1353
2019
Q2
$247K Buy
+8,679
New +$217K 0.01% 916

Other funds holding VCYT

Verition Fund Management's VCYT Position: Q1 2026 in Review

Verition Fund Management sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 11,032 shares — an estimated $464K sold.

Verition Fund Management first reported a position in VCYT in Q2 2019 and held it in 8 quarters. The position peaked at $1.46M in Q3 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Verition Fund Management reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 11,032 Veracyte shares in Q1 2026, an estimated $464K.
  • Verition Fund Management first reported a position in Veracyte in Q2 2019 and held it in 8 quarters.
  • Verition Fund Management's Veracyte position peaked at $1.46M in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.